Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
Hydrogen has been shown to have properties like antioxidant, anti-inflammatory, regulatory hormones, and anti-apoptosis. According to a review of the study, during early COVID-19(coronavirus disease 2019), the use of hydrogen may reduce destructive cytokine storms and lung damage caused by SARS-CoV-2, stimulate viscous sputum drainage, and ultimately reduce the occurrence of serious diseases. Molecular hydrogen therapy has the potential to become a neoadjuvant therapy for COVID-19, but its effectiveness and safety require extensive clinical trials and further validation. Introduction Since novel coronavirus disease (COVID-19) was first reported in Wuhan in late December 2019, it quickly became the sixth largest public health emergency and attracted international attention. As of 11:00 on 31 July 2020,17,328,002 confirmed cases were worldwide, 670,287 deaths, and a total mortality rate of 3.8%. In addition, there were no specific antiviral drugs or vaccines available to prevent COVID-19. Huang found higher plasma IL-2, IL-7, IL-10 and TNF-α concentrations in patients with severe or critical illness than in other patients. This is consistent with Wang shen's pathological results. Therefore, Chen et al. We propose that a cytokine storm is one of the most important factors in critically ill patients. Currently, there are no specific medications available for treating cytokine storms. Hydrogen, a colorless, odorless, tasteless gas, published a 2007 paper in Nature lining that inhaled 2% hydrogen can selectively remove hydroxyl radicals (OH) and ONOO −), significantly improving cerebral ischemia and reperfusion injury in rats and creating a boom in molecular biology research. Based on hydrogen. The biological effects of hydrogen have been widely studied to date. Based on its biological role in antioxidant, anti-inflammatory, anti-apoptosis, and hormone regulation, hydrogen has been determined to protect it on a variety of diseases. In particular, the small molecular properties of hydrogen ensure it is access to the alveolar quickly, suggesting its unique advantage for lung disease. In view of the current prevalence, on the basis of clinical experience, safety, operability and simplicity, this review discusses the feasibility of hydrogen as a means for the control and prevention of COVID-19 by a clinical generalization. Hydrogen and cytokine storms Immune cells can be activated to produce pro-inflammatory cytokines, including tumor necrosis factor- α (TNF-), interleukin (such as IL-1β and IL-6), and interferon- γ (IFN- γ). One role of cytokines is to activate NADPH oxidase in white blood cells resulting in the production of reactive oxygen (ROS) such as superoxides, hydroxyl radicals and monlet oxygen. In 1993, Ferrara et al. The concept of graft resistance against cytokinine storms in host disease was proposed for the first time. The discovery that SARS coronavirus infection induced interferon- γ -related cytokine storms, which may be related to immuno...